First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...

Paleontologists may have uncovered the traces of a dinosaur that may have been limping, thanks to fossilized ...

OhmBody is the first consumer wearable designed to simultaneously engage two cranial nerve pathways — the vagus and trigeminal nerves — reflecting growing scientific understanding that menstruation is ...

Patients with primary biliary cholangitis and moderate-to-severe pruritus who received seladelpar over 6 months experienced a ...

Meta analysis in obese colorectal cancer patients found robotic assisted surgery modestly reduced hospital stay versus ...

The association between multiple sclerosis and a diet focusing on fresh produce, fish, and olive oil is particularly strong ...

A systematic review and meta-analysis finds that weight-loss interventions are associated with decreased psoriasis severity ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

When a biotech company announces positive Phase 3 trial results or receives FDA approval, the market reaction is often immediate and substantial. This is not just speculation. These milestones ...

Real-world data suggest 5:2 intermittent fasting may offer modest cardiovascular benefits over calorie restriction in adults ...

“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the ...